Empowering Local Industry: SFI Health ™ EMEA Commits to South African Packing Operations
BUSINESS WIRE)--SFI Health ™ EMEA, the regional entity of SFI Health ™, a global leader in natural healthcare, is proud to announce that the packing of its branded products in South Africa will be now fully managed locally leveraging local talent and facilities. The company is known for its clinically researched products in microbiome, cognition, and well-being.
'This project is more than just a business decision—it's a commitment to our community. By sourcing locally and supporting local jobs, we're making our products more accessible and investing in the long-term well-being and economy of our region.'
Share
This initiative enhances SFI Health South Africa's ability to offer greater flexibility in pack sizes, ensuring a product portfolio that aligns more closely with the needs of South African consumers. By taking this step, the company aims to make its scientifically supported health solutions more accessible, without compromising on quality or efficacy.
Simultaneously, this initiative will have a positive ripple effect on the local economy: all packaging materials will be sourced from South African suppliers, and the products themselves will be assembled locally, thus supporting the domestic manufacturing sector.
Susan Lewis, Head of Sales Direct Markets EMEA and co-leader of the project at SFI Health ™ South Africa together with Linda Wessels, Regional Commercial Finance Manager, commented: 'This project is more than just a business decision—it's a commitment to the people of our community. By sourcing locally and supporting local jobs, we're not only making our products more accessible, but also investing in the long-term well-being and economic resilience of the region.'
In addition, this project aligns with SFI Health ™ 's broader sustainability efforts, reducing the environmental impact of transportation while fostering a more circular and locally anchored supply chain.
SFI Health™ EMEA has established its presence in South Africa since 2004 operating through a dedicated local subsidiary that manages the marketing, sales, and distribution of its key food supplement brands. The company's portfolio in South Africa includes a range of science-based products designed to support cognitive and physical well-being:
Equazen ® is a globally recognized brand formulated with a unique blend of essential fatty acids, developed to support cognitive functions.
KeenMind ® is clinically studied to enhance memory, concentration, and learning retention.
Gincosan ® combines standardized extracts of Ginkgo biloba and Panax ginseng, clinically researched to reduce mental fatigue and improve cognitive performance.
Ginsana ® is powered by a proprietary natural active ingredient shown to support immune system function and boost physical stamina, helping individuals maintain energy and endurance.
About SFI Health ™
SFI Health ™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health ™ combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health ™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health ™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information go to sfihealth.com or follow us SFI Health on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Ellington Financial Announces Estimated Book Value Per Common Share as of May 31, 2025
OLD GREENWICH, Conn., June 26, 2025--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) ("we") today announced an estimated book value per share of common stock of $13.41 as of May 31, 2025. This estimate includes the effect of the previously announced monthly dividend of $0.13 per share of common stock, to be paid on June 30, 2025 to holders of record on May 30, 2025, with the same ex-dividend date. Cautionary Statement Regarding Forward-Looking Statements Estimated book value per common share is subject to change upon completion of our month-end and quarter-end valuation procedures relating to our investment positions, and any such change could be material. There can be no assurance that our estimated book value per common share as of May 31, 2025 is indicative of what our results are likely to be for the three- or six- month periods ending June 30, 2025 or in future periods, and we undertake no obligation to update or revise our estimated book value per common share prior to issuance of financial statements for such periods. This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from our beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as "believe," "expect," "anticipate," "estimate," "project," "plan," "continue," "intend," "should," "would," "could," "goal," "objective," "will," "may," "seek" or similar expressions or their negative forms, or by references to strategy, plans, or intentions. Forward-looking statements are based on our beliefs, assumptions and expectations of our future operations, business strategies, performance, financial condition, liquidity and prospects, taking into account information currently available to us. These beliefs, assumptions, and expectations are subject to risks and uncertainties and can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity, results of operations and strategies may vary materially from those expressed or implied in our forward-looking statements. The following factors are examples of those that could cause actual results to vary from our forward-looking statements: changes in interest rates and the market value of our investments, market volatility, changes in mortgage default rates and prepayment rates, our ability to borrow to finance our assets, changes in government regulations affecting our business, our ability to maintain our exclusion from registration under the Investment Company Act of 1940, our ability to maintain our qualification as a real estate investment trust, or "REIT," and other changes in market conditions and economic trends, such as changes to fiscal or monetary policy, heightened inflation, slower growth or recession, and currency fluctuations. Furthermore, forward-looking statements are subject to risks and uncertainties, including, among other things, those described under Item 1A of our Annual Report on Form 10-K, which can be accessed through our website at or at the SEC's website ( Other risks, uncertainties, and factors that could cause actual results to differ materially from those projected or implied may be described from time to time in reports we file with the SEC, including reports on Forms 10-Q, 10-K and 8-K. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. This release and the information contained herein do not constitute an offer of any securities or solicitation of an offer to purchase securities. About Ellington Financial Ellington Financial invests in a diverse array of financial assets, including residential and commercial mortgage loans and mortgage-backed securities, reverse mortgage loans, mortgage servicing rights and related investments, consumer loans, asset-backed securities, collateralized loan obligations, non-mortgage and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments. Ellington Financial is externally managed and advised by Ellington Financial Management LLC, an affiliate of Ellington Management Group, L.L.C. View source version on Contacts Investors:Ellington FinancialInvestor Relations(203) 409-3575info@ orMedia:Amanda Shpiner/Grace CartwrightGasthalter & Ellington Financial(212) 257-4170ellington@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
35 minutes ago
- Business Wire
Gold Resource Corporation Closes US$6.28M Debt Facility
DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the 'Company'), along with its wholly owned subsidiary, Don David Gold Mexico ('DDGM'), is pleased to announce the execution of a loan agreement with Francisco Javier Reyes de la Campa and Jaluca Limited in the amount of US$6.28 million, to be used for working capital. 'The funds from this loan will allow us to develop and begin production from the new Three Sisters area of our Don David Gold Mine,' said Allen Palmiere, the Company's President and CEO. 'Additionally, we will be purchasing replacement mining equipment and funding upgrades in the mill. This loan and the proceeds of equity issuances earlier in the year provide us with the capital to execute on our plans to increase productivity and profitability.' In connection with the loan agreement, the Company has also issued a common stock purchase warrant to an affiliate of Mr. Reyes de la Campa for the purchase of up to 1,500,000 shares of the Company's common stock at an exercise price per share of $0.65. The warrant is exercisable immediately upon issuance and expires on June 26, 2027. The warrant provides for customary adjustments in the event of stock dividends, splits and the like, and includes terms relating to the occurrence of a fundamental transaction, such as a merger, reorganization or recapitalization. Key Facility Details The key terms of the facility include the following: Facility Amount – US$6,280,000 Term – 18 months, with maturity date of December 26, 2026 Interest Rate – Secured Overnight Financing Rate ('SOFR') plus 5% per annum Repayment – Principal amount of the loan, all accrued interest, and all other obligations are due and payable in full, if not paid earlier, on the maturity date Warrant – Provides for the issuance of warrants for 1,500,000 shares of the Company's common stock for an exercise price per share of $0.65 and expires on June 26, 2027. About GRC: Gold Resource Corporation is a gold and silver producer, developer, and explorer with its operations centered on the Don David Gold Mine in Oaxaca, Mexico. Base metals, critical to the United States, are also produced as a by-product. Under the direction of an experienced board and senior leadership team, the Company's focus is to unlock the significant upside potential of its existing infrastructure and large land position surrounding the mine in Oaxaca, Mexico and to develop the Back Forty Project in Michigan, USA.
Business Wire
35 minutes ago
- Business Wire
DNOW Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of DNOW Inc. is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of DNOW Inc. (NYSE: DNOW) and MRC Global Inc. is fair to DNOW shareholders. Upon completion of the proposed transaction, DNOW shareholders will own approximately 56.5% of the combined company on a fully diluted basis. Halper Sadeh encourages DNOW shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether DNOW and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for DNOW shareholders; and (2) disclose all material information necessary for DNOW shareholders to adequately assess and value the merger consideration. On behalf of DNOW shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
